Sanjay Nayak Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Sanjay Nayak is Chief Strategy Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 283,485 shares of OCUL, which is worth approximately $2.18 Million. The most recent transaction as insider was on Feb 24, 2025, when has been sold 1,895 shares (Common Stock) at a price of $6.84 per share, resulting in proceeds of $12,961. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 283K
62.57% 3M change
57.23% 12M change
Total Value Held $2.18 Million

Sanjay Nayak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
SELL
Open market or private sale
$12,961 $6.84 p/Share
1,895 Reduced 0.66%
283,485 Common Stock
Feb 11 2025
BUY
Grant, award, or other acquisition
-
111,000 Added 28.0%
285,380 Common Stock
Nov 25 2024
SELL
Open market or private sale
$16,326 $9.0 p/Share
1,814 Reduced 1.03%
174,380 Common Stock
Aug 23 2024
SELL
Open market or private sale
$16,524 $9.02 p/Share
1,832 Reduced 1.03%
176,194 Common Stock
May 23 2024
SELL
Open market or private sale
$13,280 $5.84 p/Share
2,274 Reduced 1.26%
178,026 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
80,300 Added 30.81%
180,300 Common Stock
SN

Sanjay Nayak

Chief Strategy Officer
Bedford, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL